Dry Macular Degeneration Drugs Development Landscape Report 2021: Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Dry (Atrophic) Macular Degeneration (Ophthalmology) - Drugs in Development, 2021" report has been added to ResearchAndMarkets.com's offering. Dry (Atrophic) Macular Degeneration (Ophthalmology) - Drugs in Development, 2021 provides an overview of the Dry (Atrophic) Macular Degeneration pipeline landscape. The report provides comprehensive information on the therapeutics under development for Dry (Atrophic) Macular Degeneration, complete with analysis by Stage of De